Postpartum Haemorrhage
Conditions
Interventions
Heat stable Carbetocin
Oxytocin
Sponsors
Faiza Lawan Mohammed
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All pregnant women • with singleton gestation • at term • at low risk of having PPH • in early active phase of first stage of labour who were to have spontaneous vaginal delivery
Exclusion criteria
Exclusion criteria: 1. Pregnant women with medical disorders such as hepatic, cardiovascular, renal diseases, epilepsy, uncontrolled diabetes mellitus, sickle cell disease. 2. Gestational age <37 weeks. 3. Pregnant women with a previous caesarean scar, grandmultiparous women, multiple gestation, fetal macrosomia, previous PPH, anaemia, induction of labour, antepartum haemorrhage. 4. All pregnant women undergoing caesarean delivery. 5. Pregnant women in advanced labour and too distressed to provide informed consent. 6. Pregnant women in whom Oxytocin or Carbetocin are contraindicated: allergies to Oxytocin and its homologues.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of women with blood loss >/=500mls in each group | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean blood loss at delivery (in mls) in each group;Proportion of women receiving additional uterotonics;Proportion of women requiring additional surgical procedures (manual removal of placenta, uterine compression sutures, uterine or internal iliac artery ligation or hysterectomy);Proportion of women needing blood transfusion;Side effects of drugs;Cost effectiveness ratio | — |
Countries
Nigeria
Contacts
Public ContactMaryam;Idris Usman Bashir;Takai
Resaerch clinician;Consultant
Outcome results
None listed